NO124518B - - Google Patents
Download PDFInfo
- Publication number
- NO124518B NO124518B NO168419A NO16841967A NO124518B NO 124518 B NO124518 B NO 124518B NO 168419 A NO168419 A NO 168419A NO 16841967 A NO16841967 A NO 16841967A NO 124518 B NO124518 B NO 124518B
- Authority
- NO
- Norway
- Prior art keywords
- capsules
- wax
- solvent
- capsule
- walls
- Prior art date
Links
- 239000002775 capsule Substances 0.000 claims description 79
- 239000001993 wax Substances 0.000 claims description 36
- 239000002904 solvent Substances 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- 239000002861 polymer material Substances 0.000 claims description 11
- 239000012188 paraffin wax Substances 0.000 claims description 9
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 8
- 239000001856 Ethyl cellulose Substances 0.000 claims description 7
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 7
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 7
- 229920001249 ethyl cellulose Polymers 0.000 claims description 7
- 229920001600 hydrophobic polymer Polymers 0.000 claims description 5
- 238000009792 diffusion process Methods 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 2
- 230000000717 retained effect Effects 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 description 22
- 238000011282 treatment Methods 0.000 description 17
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000005538 encapsulation Methods 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000011162 core material Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- -1 polyethylene Polymers 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 description 2
- 229960003733 phenylephrine hydrochloride Drugs 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZHVLGOLHHYJSBZ-UHFFFAOYSA-N 1-phenylpropan-2-amine;phosphoric acid Chemical compound OP(O)(O)=O.CC(N)CC1=CC=CC=C1 ZHVLGOLHHYJSBZ-UHFFFAOYSA-N 0.000 description 1
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229920002433 Vinyl chloride-vinyl acetate copolymer Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- JOSWYUNQBRPBDN-UHFFFAOYSA-P ammonium dichromate Chemical compound [NH4+].[NH4+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O JOSWYUNQBRPBDN-UHFFFAOYSA-P 0.000 description 1
- 229940008238 amphetamine sulfate Drugs 0.000 description 1
- PYHRZPFZZDCOPH-UHFFFAOYSA-N amphetamine sulfate Chemical compound OS(O)(=O)=O.CC(N)CC1=CC=CC=C1.CC(N)CC1=CC=CC=C1 PYHRZPFZZDCOPH-UHFFFAOYSA-N 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002415 cerumenolytic agent Substances 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000007771 core particle Substances 0.000 description 1
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229960004815 meprobamate Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000019448 polyvinylpyrrolidone-vinyl acetate copolymer Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000004018 waxing Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
- B01J13/22—Coating
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2989—Microcapsule with solid core [includes liposome]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Record Information Processing For Printing (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55527966A | 1966-06-06 | 1966-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO124518B true NO124518B (pl) | 1972-05-02 |
Family
ID=24216671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO168419A NO124518B (pl) | 1966-06-06 | 1967-06-01 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3623997A (pl) |
| AT (1) | AT280217B (pl) |
| BE (1) | BE699324A (pl) |
| CH (1) | CH471597A (pl) |
| CS (1) | CS151455B2 (pl) |
| DE (1) | DE1619794A1 (pl) |
| DK (1) | DK126842B (pl) |
| ES (1) | ES341431A1 (pl) |
| FI (1) | FI48679C (pl) |
| GB (1) | GB1117270A (pl) |
| NL (1) | NL142092B (pl) |
| NO (1) | NO124518B (pl) |
| SE (1) | SE311137B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS518876B2 (pl) * | 1972-10-03 | 1976-03-22 | ||
| JPS5432614A (en) * | 1977-08-11 | 1979-03-10 | Tanabe Seiyaku Co Ltd | Preparation of microcapsules containing pharmaceuticals |
| US5122384A (en) * | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5057594A (en) * | 1989-08-17 | 1991-10-15 | Eastman Kodak Company | Ultraviolet light-absorbing compounds and sunscreen formulations and polymeric materials containing such compounds or residues thereof |
| US5149775A (en) * | 1991-01-25 | 1992-09-22 | Eastman Kodak Company | Method for purifying high molecular weight vinylpyridine/styrene polymers from solution |
| JP3313124B2 (ja) * | 1991-07-31 | 2002-08-12 | 森下仁丹株式会社 | 親水性物質を内容物とするシームレスカプセルおよびその製法 |
| KR970008262B1 (ko) * | 1993-10-12 | 1997-05-22 | 주식회사 엘지화학 | 구형 축열캡슐 및 그의 제조 방법 |
| DE19835346A1 (de) * | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
| AU2001252231A1 (en) * | 2000-03-27 | 2001-10-08 | Givaudan Sa | Disposable cleaning cloth |
| GB0322848D0 (en) * | 2003-09-30 | 2003-10-29 | Alpharma Ltd | Tetracycline controlled release pharmaceutical dosage form |
| DE102005001332A1 (de) * | 2005-01-11 | 2006-07-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
| US20080277596A1 (en) * | 2007-05-08 | 2008-11-13 | Southwest Research Institute | Impact Indicating Microcapsules |
| CA2936741C (en) | 2014-10-31 | 2018-11-06 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| CN112375109B (zh) * | 2020-11-20 | 2023-03-28 | 华东理工大学 | 利用烷基酚聚氧乙烯聚氧丙烯醚npe-108分离纯化螺旋霉素 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL256671A (pl) * | 1960-10-08 | 1965-02-15 | ||
| US3155590A (en) * | 1962-08-02 | 1964-11-03 | Ncr Co | Encapsulation process and its product |
-
1966
- 1966-06-06 US US555279A patent/US3623997A/en not_active Expired - Lifetime
-
1967
- 1967-05-03 GB GB20455/67A patent/GB1117270A/en not_active Expired
- 1967-06-01 BE BE699324D patent/BE699324A/xx not_active IP Right Cessation
- 1967-06-01 NO NO168419A patent/NO124518B/no unknown
- 1967-06-02 FI FI671555A patent/FI48679C/fi active
- 1967-06-02 DK DK289667AA patent/DK126842B/da not_active IP Right Cessation
- 1967-06-03 DE DE19671619794 patent/DE1619794A1/de active Pending
- 1967-06-05 CS CS4110A patent/CS151455B2/cs unknown
- 1967-06-05 SE SE7866/67A patent/SE311137B/xx unknown
- 1967-06-06 CH CH801167A patent/CH471597A/fr not_active IP Right Cessation
- 1967-06-06 NL NL676707848A patent/NL142092B/xx not_active IP Right Cessation
- 1967-06-06 AT AT526267A patent/AT280217B/de not_active IP Right Cessation
- 1967-06-06 ES ES341431A patent/ES341431A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL142092B (nl) | 1974-05-15 |
| CS151455B2 (pl) | 1973-10-19 |
| GB1117270A (en) | 1968-06-19 |
| BE699324A (pl) | 1967-11-16 |
| FI48679C (fi) | 1974-12-10 |
| US3623997A (en) | 1971-11-30 |
| DE1619794A1 (pl) | 1971-09-16 |
| DK126842B (da) | 1973-08-27 |
| NL6707848A (pl) | 1967-12-07 |
| CH471597A (fr) | 1969-04-30 |
| ES341431A1 (es) | 1968-07-01 |
| SE311137B (pl) | 1969-06-02 |
| FI48679B (pl) | 1974-09-02 |
| AT280217B (de) | 1970-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO124518B (pl) | ||
| US3737337A (en) | Process for the production of microgranulates | |
| US3516943A (en) | Replacement of capsule contents by diffusion | |
| DK173005B1 (da) | En fremgangsmåde til fremstilling af vanduopløseligt polymerpulver, der kan redispergeres i en væskefase og en fremstilling | |
| JP2001504452A (ja) | 活性物質をポリマーで被覆したマイクロカプセルの製法と特にこの方法で得られる新規マイクロカプセル | |
| CN107410829B (zh) | 一种提高多糖/蛋白复合物乳化稳定性的方法 | |
| JP2017014528A (ja) | 多孔質セルロースビーズの製造方法 | |
| NO154174B (no) | Fremgangsm¨te og anordning for forankring av r¯rledninger p¨ sj¯bunnen. | |
| DK142605B (da) | Fremgangsmåde til fremstilling af små kapsler. | |
| US5075432A (en) | Spherical cyclodextrin polymer beads | |
| JP2010179095A (ja) | 水又は水溶液を含有するマイクロカプセル及びその製造方法 | |
| CN108409676A (zh) | 一种控制nto晶体形貌与粒度的方法 | |
| DK146054B (da) | Fremgangsmaade til fremstilling af smaa kapsler | |
| US3657144A (en) | Encapsulation process | |
| US5378413A (en) | Process for preparing microcapsules having gelatin walls crosslinked with quinone | |
| CN111500380A (zh) | 一种可通过离子浓度控制释放的组合物及其制备方法 | |
| Vinceković et al. | Release of Trichoderma viride spores from microcapsules simultaneously loaded with chemical and biological agents | |
| JPS6259609B2 (pl) | ||
| JPH0556761B2 (pl) | ||
| US4948814A (en) | Ion exchanger based on cross-linked glucomannan | |
| CS249368B1 (en) | Method of pearls detran materials production for gel chromatography | |
| NO124764B (pl) | ||
| US3937798A (en) | Method of controlling hydrogen ion concentration by microcapsules | |
| US2146033A (en) | Handling of sensitive materials | |
| NO160706B (no) | Innretning for transport av legemer ved hjelp av en i en roerledning stroemmende vaeske. |